BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA's Overreach on Compounded Peptides FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.